Mine sisu juurde

aclarubicin

Lehekülje sisu ei toetata teistes keeltes.

keemiline ühend

üksikjuht nähtusest

type of chemical entity

mille alamklass

methyl (1R,2R,4S)-4-[(2R,5S,6S)-4-(dimethylamino)-5-[(2S,4S,5S,6S)-4-hydroxy-6-methyl-5-[(2R,6S)-6-methyl-5-oxooxan-2-yl]oxyoxan-2-yl]oxy-6-methyloxan-2-yl]oxy-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate[11]

kasutus

keemiline struktuur

mass/kaal

811,341519996 aatommassiühik[11]

stereoisomer of

Methyl 2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-({2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-(6-methyl-5-oxooxan-2-yl)hexopyranosyl]-3-(dimethylamino)hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydrotetracene-1-carboxy late[6]

chemical formula

C₄₂H₅₃NO₁₅[8]

canonical SMILES

CCC1(CC(C2=C(C1C(=O)OC)C=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CCC(=O)C(O7)C)O)N(C)C)O[8]

isomeric SMILES

CC[C@@]1(O)C[C@H](O[C@H]2C[C@@H]([C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)N(C)C)C5=C(C=C6C(=O)C7=C(C(O)=CC=C7)C(=O)C6=C5O)[C@H]1C(=O)OC[1]

found in taxon

Streptomyces galilaeus[12][13][14][15][16][17]
Micromonospora[18]

subjektil on roll

antineoplastic antibiotics[19]
topoisomerase II inhibitor[19]

NCI Thesaurus ID

C202[1]

Viited

  1. 1,0 1,1 1,2 1,3 1,4 1,5 1,6 Global Substance Registration System, 14. veebruar 2018, 74KXF8I502
  2. CAS Common Chemistry, 10. aprill 2021, USZYSDMBJDPRIF-SVEJIMAYSA-N, https://commonchemistry.cas.org/detail?cas_rn=57576-44-0
  3. 3,0 3,1 3,2 3,3 3,4 3,5 3,6 USZYSDMBJDPRIF-SVEJIMAYSA-N, InChIKey
  4. UniChem
  5. OpenAlex, 26. jaanuar 2022, https://docs.openalex.org/download-snapshot/snapshot-data-format
  6. 6,0 6,1 6,2 inferred from InChIKey
  7. ChEBI release 2020-09-01
  8. 8,0 8,1 8,2 PubChem
  9. ECHA Substance Infocard database, 27. detsember 2018, 100.055.277, Aclarubicin, CAS no.: 57576-44-0
  10. Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard
  11. 11,0 11,1 inferred from SMILES
  12. New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. I. Isolation and characterization of various blocked mutants
  13. 5001112 Antitumor antibiotic kedarcidin
  14. Antitumor anthracycline antibiotics, aclacinomycin A and analogues. II. Structural determination
  15. Cloning and characterization of Streptomyces galilaeus aclacinomycins polyketide synthase (PKS) cluster
  16. A gene cluster from Streptomyces galilaeus involved in glycosylation of aclarubicin
  17. Expression, purification, and characterization of AknX anthrone oxygenase, which is involved in aklavinone biosynthesis in Streptomyces galilaeus
  18. Antifungal anthracycline antibiotics, spartanamicins A and B from Micromonospora spp
  19. 19,0 19,1 Medical Subject Headings, 15. märts 2018, D015250